<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">oncotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский онкологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian journal of oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-4861</issn><issn pub-type="epub">2312-3168</issn><publisher><publisher-name>Tomsk National Research Medical Сепtеr of the Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21294/1814-4861-2019-18-1-50-55</article-id><article-id custom-type="elpub" pub-id-type="custom">oncotomsk-959</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛАБОРАТОРНЫЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LABORATORY AND EXPERIMENTAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Активация сигнального пути интерферона-альфа ресвератролом, генистеином и кверцетином</article-title><trans-title-group xml:lang="en"><trans-title>Activation of interferon-α signaling by resveratrol, genistein and quercetin</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Власова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vlasova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Власова Ольга Александровна, младший научный сотрудник отдела химического канцерогенеза.</p><p>г. Москва, 115478, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Olga A. Vlasova, Junior Researcher, Department of Chemical Carcinogenesis</p><p>24, Kashirskoe shosse, 115478-Moscow</p></bio><email xlink:type="simple">olya_vlasov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борунова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Borunova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Борунова Анна Анатольевна, кандидат медицинских наук, старший научный сотрудник лаборатории иммунологии опухолеи</p><p>г. Москва, 115478, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Anna A. Borunova, PhD, Senior Researcher, Laboratory of Tumor Immunology</p><p>24, Kashirskoe shosse, 115478-Moscow</p></bio><email xlink:type="simple">borunova_a@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сафина</surname><given-names>А.</given-names></name><name name-style="western" xml:lang="en"><surname>Safina</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сафина Альфия, кандидат биологических наук, старший научный сотрудник лаборатории биологии клеточного стресса онкологического центра Розвел Парк</p><p>США, Баффало, 14263, ул. Элм Картон</p></bio><bio xml:lang="en"><p>Alfiya Safina, PhD, Research Fellow, Laboratory of Cell Stress Biology</p><p>Elm Carlton Street, 14263-Buffalo, NY, USA.</p></bio><email xlink:type="simple">alfiya.safina@roswellpark.org</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сметанина</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smetanina</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сметанина Инна Васильевна, лаборант‐исследователь отдела химического канцерогенеза</p><p>г. Москва, 115478, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Inna V. Smetanina, Laboratory Assistant, Department of Chemical Carcinogenesis</p><p>24, Kashirskoe shosse, 115478-Moscow</p></bio><email xlink:type="simple">innasmet@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1967-9637</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лесовая</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lesovaya</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лесовая Екатерина Андреевна, кандидат биологических наук, старший научный сотрудник отдела химического канцерогенеза</p><p>SPIN‐код: 7593‐2167. Researcher ID (WOS): J‐7790‐2015. Author ID (Scopus): 583044.</p><p>г. Москва, 115478, Каширское шоссе, 24;г. Рязань, 390026, ул. Высоковольтная, 9.</p></bio><bio xml:lang="en"><p>Ekaterina A. Lesovaya, PhD, Senior Researcher, Department of Chemical Carcinogenesis</p><p>24, Kashirskoe shosse, 115478-Moscow;9, Vysokovol’tnaya Street, 390026-Ryazan</p></bio><email xlink:type="simple">lesovenok@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белицкий</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belitsky</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белицкий Геннадий Альтерович, доктор медицинских наук, профессор, ведущий научный сотрудник отдела химического канцерогенеза</p><p>SPIN‐код: 4037‐0033. Researcher ID (WOS): L‐3062‐2015. Author ID (Scopus): 107231.</p><p>г. Москва, 115478, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Gennady A. Belitsky, MD, PhD, DSc, Professor, Leading researcher, Department of Chemical Carcinogenesis</p><p>24, Kashirskoe shosse, 115478-Moscow</p></bio><email xlink:type="simple">belitsga@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Заботина</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zabotina</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Заботина Татьяна Николаевна, доктор биологических наук, заведующая централизованным клинико‐лабораторным отделом</p><p>г. Москва, 115478, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Tatiana N. Zabotina, PhD, DSc, Head of Clinical‐laboratory Department</p><p>24, Kashirskoe shosse, 115478-Moscow</p></bio><email xlink:type="simple">tatzabotina@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гурова</surname><given-names>К.</given-names></name><name name-style="western" xml:lang="en"><surname>Gurova</surname><given-names>K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гурова Катерина, кандидат медицинских наук, заведующая лабораторией биологии клеточного стресса онкологического центра Розвел Парк.</p><p>США, Баффало, 14263, ул. Элм Картон</p></bio><bio xml:lang="en"><p>Katerina Gurova, PhD, Head of the Laboratory of Cell Stress Biology</p><p>Elm Carlton Street, 14263-Buffalo, NY, USA.</p></bio><email xlink:type="simple">katerina.gurova@roswellpark.org</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8599-6833</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кирсанов</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirsanov</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кирсанов Кирилл Игоревич, кандидат биологических наук, заведующий лабораторией канцерогенных веществ отдела химического канцерогенеза</p><p>SPIN‐ код: 7329‐7263. Researcher ID (WOS): L‐3062‐2015. Author ID (Scopus): 184421.</p><p>г. Москва, 115478, Каширское шоссе, 24;г. Москва, 117198, ул. Миклухо-Маклая, 6</p></bio><bio xml:lang="en"><p>Kirill I. Kirsanov, PhD, Head of Laboratory of Chemical Carcinogens</p><p>24, Kashirskoe shosse, 115478-Moscow;6, Miklukho-Maklaya Street, 117198-Moscow</p></bio><email xlink:type="simple">kkirsanov85@yandex.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9710-8178</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Якубовская</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakubovskaya</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Якубовская Марианна Геннадиевна, доктор медицинских наук, заведующая отделом химического канцерогенеза</p><p>SPIN‐код: 6858‐3880. Researcher ID (WOS): R‐6984‐2016. Author ID (Scopus): 583045.</p><p>г. Москва, 115478, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Marianna G. Yakubovskaya, MD, PhD, DSc, Head of Department of Chemical Carcinogenesis</p><p>24, Kashirskoe shosse, 115478-Moscow</p></bio><email xlink:type="simple">mgyakubovskaya@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России<country>Россия</country></aff><aff xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Онкологический центр Розвел Парк<country>Соединённые Штаты Америки</country></aff><aff xml:lang="en">Roswell Park Cancer Center<country>United States</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России;&#13;
ФГБОУ ВО «Рязанский государственный медицинский университет» Минздрава России<country>Россия</country></aff><aff xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology;&#13;
I.P. Pavlov Ryazan State Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России;&#13;
ФГАОУ ВО «Российский университет дружбы народов»<country>Россия</country></aff><aff xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology;&#13;
RUDN University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>27</day><month>02</month><year>2019</year></pub-date><volume>18</volume><issue>1</issue><fpage>50</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Власова О.А., Борунова А.А., Сафина А., Сметанина И.В., Лесовая Е.А., Белицкий Г.А., Заботина Т.Н., Гурова К., Кирсанов К.И., Якубовская М.Г., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Власова О.А., Борунова А.А., Сафина А., Сметанина И.В., Лесовая Е.А., Белицкий Г.А., Заботина Т.Н., Гурова К., Кирсанов К.И., Якубовская М.Г.</copyright-holder><copyright-holder xml:lang="en">Vlasova O.A., Borunova A.A., Safina A., Smetanina I.V., Lesovaya E.A., Belitsky G.A., Zabotina T.N., Gurova K., Kirsanov K.I., Yakubovskaya M.G.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.siboncoj.ru/jour/article/view/959">https://www.siboncoj.ru/jour/article/view/959</self-uri><abstract><p>Ресвератрол, кверцетин и генистеин, относящиеся к полифенолам вторичных метаболитов растений, обладают антиканцерогенным и противовирусным эффектами, реализуемыми в результате их плейотропного действия на различные макромолекулы клетки. Эти соединения могут взаимодействовать с ДНК, не образуя ковалентные связи. При этом может происходить изменение пространственных, физико-химических и структурных характеристик ДНК, что может приводить к нарушению функционирования белков метаболизма ДНК и вызывать дестабилизацию хроматина. Такие эффекты были описаны для нового противоопухолевого препарата Кураксина CBL0137, причем индуцированная данным соединением дестабилизация хроматина приводила к активации сигнального пути интерферона-α. Используя клеточную линию HeLa с трансгенным флуоресцентным белком mCherry, содержащим в промоторной области консенсусный сайт связывания интерферона-α (ISRE), мы продемонстрировали дозозависимый стимулирующий эффект ресвератрола, кверцетина и генистеина на активность сигнального пути интерферона-α. Использование прижизненной флуоресцентной микроскопии на клеточной линии HT1080 c трансгенным флуоресцентно-меченным гистоном H1.5 позволило продемонстрировать, что данные полифенолы вызывают перераспределение данного линкерного гистона в ядрах клеток. Полученные нами данные свидетельствуют о возможности существования ДНК-зависимого механизма реализации противоопухолевого действия растительных полифенолов и необходимости дальнейшего изучения влияния полифенолов на структуру хроматина и связанного с этим изменения функционирования генома, в частности регуляции сигнального пути интерферона-α.</p></abstract><trans-abstract xml:lang="en"><p>Resveratrol, genistein and quercetin from the group of polyphenols from secondary plant metabolites reveal cancer preventive and antivirus effects realized via their pleiotropic influence on the different macromolecules in cells. These compounds can interact with DNA without the formation of covalent bonds. This process is usually followed by changes in spatial, physical-chemical and structural DNA characteristics that can result in disfunction of DNA metabolism enzymes and chromatin destabilization. Similar effects were described for anticancer drug Curaxine CBL0137 in association with activation of interferon-α signaling. We demonstrated dose-dependent stimulating effects of resveratrol, genistein and quercetin on interferon-α signaling using HeLa cells expressed mCherry protein with interferon-stimulated response elements (ISRE) in promoter. Furthermore, it was shown by live-cell fluorescent microscopy in HT1080 cells with mCherry-labeled histone H1.5 that described polyphenols induced the redistribution of this linker histone in cell nuclei. The data obtained suggest an existence of DNA-dependent mechanism of anticancer effects of plant polyphenols and a need for further study of crosslinks between the polyphenols’ influence on chromatin structure and the changes in genome function, in particular, induction of interferon- interferon-α signaling.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>растительные полифенолы</kwd><kwd>ресвератрол</kwd><kwd>генистеин</kwd><kwd>кверцетин</kwd><kwd>интерферон-α</kwd><kwd>гистон Н1</kwd><kwd>макромолекулы клетки</kwd><kwd>флуоресцентная микроскопия</kwd><kwd>ферменты метаболизма</kwd></kwd-group><kwd-group xml:lang="en"><kwd>plant polyphenols</kwd><kwd>resveratrol</kwd><kwd>genistein</kwd><kwd>quercetin</kwd><kwd>interferon-α</kwd><kwd>histone Н1</kwd><kwd>macromolecules</kwd><kwd>fluorescence microscopy</kwd><kwd>metabolism enzymes</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Pezzuto J.M. Resveratrol: Twenty Years of Growth, Development and Controversy. Biomol Ther (Seoul). 2018 Oct 11. doi: 10.4062/ biomolther.2018.176.</mixed-citation><mixed-citation xml:lang="en">Pezzuto J.M. Resveratrol: Twenty Years of Growth, Development and Controversy. Biomol Ther (Seoul). 2018 Oct 11. doi: 10.4062/ biomolther.2018.176.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Russo M., Russo G.L., Daglia M., Kasi P.D., Ravi S., Nabavi S.F., Nabavi S.M. Understanding genistein in cancer: The «good» and the «bad» effects: A review. Food Chem. 2016 Apr 1; 196: 589–600. doi: 10.1016/j. foodchem.2015.09.085.</mixed-citation><mixed-citation xml:lang="en">Russo M., Russo G.L., Daglia M., Kasi P.D., Ravi S., Nabavi S.F., Nabavi S.M. Understanding genistein in cancer: The «good» and the «bad» effects: A review. Food Chem. 2016 Apr 1; 196: 589–600. doi: 10.1016/j. foodchem.2015.09.085.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rauf A., Imran M., Khan I.A., Ur-Rehman M., Gilani S.A., Mehmood Z., Mubarak M.S. Anticancer potential of quercetin: A comprehensive review. Phytother Res. 2018 Nov; 32 (11): 2109–2130. doi: 10.1002/ ptr.6155.</mixed-citation><mixed-citation xml:lang="en">Rauf A., Imran M., Khan I.A., Ur-Rehman M., Gilani S.A., Mehmood Z., Mubarak M.S. Anticancer potential of quercetin: A comprehensive review. Phytother Res. 2018 Nov; 32 (11): 2109–2130. doi: 10.1002/ ptr.6155.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila). 2009 May; 2 (5): 409–18. doi: 10.1158/1940‐6207.CAPR‐08‐0160.</mixed-citation><mixed-citation xml:lang="en">Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila). 2009 May; 2 (5): 409–18. doi: 10.1158/1940‐6207.CAPR‐08‐0160.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Whitsett T.G.Jr., Lamartiniere C.A. Genistein and resvera‐ trol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert Rev Anticancer Ther. 2006; 6 (12): 1699–706. doi: 10.1586/14737140.6.12.1699.</mixed-citation><mixed-citation xml:lang="en">Whitsett T.G.Jr., Lamartiniere C.A. Genistein and resvera‐ trol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert Rev Anticancer Ther. 2006; 6 (12): 1699–706. doi: 10.1586/14737140.6.12.1699.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr. 1995 Mar; 125 (3 Suppl): 777S783S. doi: 10.1093/ jn/125.3_Suppl.777S.</mixed-citation><mixed-citation xml:lang="en">Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr. 1995 Mar; 125 (3 Suppl): 777S783S. doi: 10.1093/ jn/125.3_Suppl.777S.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kiskova T., Ekmekcioglu C., Garajova M., Orendas P., Bojkova B., Bobrov N., Jager W., Kassayova M., Thalhammer T. A combination of resveratrol and melatonin exerts chemopreventive effects in N‐methyl‐N‐ nitrosourea‐induced rat mammary carcinogenesis. Eur J Cancer Prev. 2012 Mar; 21 (2): 163–70. doi: 10.1097/CEJ.0b013e32834c9c0f.</mixed-citation><mixed-citation xml:lang="en">Kiskova T., Ekmekcioglu C., Garajova M., Orendas P., Bojkova B., Bobrov N., Jager W., Kassayova M., Thalhammer T. A combination of resveratrol and melatonin exerts chemopreventive effects in N‐methyl‐N‐ nitrosourea‐induced rat mammary carcinogenesis. Eur J Cancer Prev. 2012 Mar; 21 (2): 163–70. doi: 10.1097/CEJ.0b013e32834c9c0f.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fantini M., Benvenuto M., Masuelli L., Frajese G.V., Tresoldi I., Modesti A., Bei R. In vitro and in vivo antitumoral effects of combina‐ tions of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Mol Sci. 2015 Apr 24; 16 (5): 9236–82. doi: 10.3390/ijms16059236.</mixed-citation><mixed-citation xml:lang="en">Fantini M., Benvenuto M., Masuelli L., Frajese G.V., Tresoldi I., Modesti A., Bei R. In vitro and in vivo antitumoral effects of combina‐ tions of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Mol Sci. 2015 Apr 24; 16 (5): 9236–82. doi: 10.3390/ijms16059236.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jantan I., Ahmad W., Bukhari S.N. Plant‐derived immunomodula‐ tors: an insight on their preclinical evaluation and clinical trials. Front Plant Sci. 2015 Aug 25; 6: 655. doi: 10.3389/fpls.2015.00655.</mixed-citation><mixed-citation xml:lang="en">Jantan I., Ahmad W., Bukhari S.N. Plant‐derived immunomodula‐ tors: an insight on their preclinical evaluation and clinical trials. Front Plant Sci. 2015 Aug 25; 6: 655. doi: 10.3389/fpls.2015.00655.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Britton R.G., Kovoor C., Brown K. Direct molecular targets of res‐ veratrol: identifying key interactions to unlock complex mechanisms. Ann NY Acad Sci. 2015 Aug; 1348 (1): 124–33. doi: 10.1111/nyas.12796.</mixed-citation><mixed-citation xml:lang="en">Britton R.G., Kovoor C., Brown K. Direct molecular targets of res‐ veratrol: identifying key interactions to unlock complex mechanisms. Ann NY Acad Sci. 2015 Aug; 1348 (1): 124–33. doi: 10.1111/nyas.12796.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nagaraju G.P., Zafar S.F., El-Rayes B.F. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr Rev. 2013 Aug; 71 (8): 562–72. doi: 10.1111/nure.12044.</mixed-citation><mixed-citation xml:lang="en">Nagaraju G.P., Zafar S.F., El-Rayes B.F. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr Rev. 2013 Aug; 71 (8): 562–72. doi: 10.1111/nure.12044.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chirumbolo S. Quercetin in cancer prevention and therapy. Integr Can‐ cer Ther. 2013 Mar; 12 (2): 97–102. doi: 10.1177/1534735412448215.</mixed-citation><mixed-citation xml:lang="en">Chirumbolo S. Quercetin in cancer prevention and therapy. Integr Can‐ cer Ther. 2013 Mar; 12 (2): 97–102. doi: 10.1177/1534735412448215.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kanakis C.D., Tarantilis P.A., Polissiou M.G., Diamantoglou S., Tajmir-Riahi H.A. DNA interaction with naturally occurring antioxidant flavonoids quercetin, kaempferol, and delphinidin. J Biomol Struct Dyn. 2005; 22 (6): 719–24. doi: 10.1080/07391102.2005.10507038.</mixed-citation><mixed-citation xml:lang="en">Kanakis C.D., Tarantilis P.A., Polissiou M.G., Diamantoglou S., Tajmir-Riahi H.A. DNA interaction with naturally occurring antioxidant flavonoids quercetin, kaempferol, and delphinidin. J Biomol Struct Dyn. 2005; 22 (6): 719–24. doi: 10.1080/07391102.2005.10507038.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang S., Sun X., Jing Z., Qu F. Spectroscopic analysis on the resveratrol‐DNA binding interactions at physiological pH. Spectrochim Acta A Mol Biomol Spectrosc. 2011 Nov; 82 (1): 213–6. doi: 10.1016/j. saa.2011.07.037.</mixed-citation><mixed-citation xml:lang="en">Zhang S., Sun X., Jing Z., Qu F. Spectroscopic analysis on the resveratrol‐DNA binding interactions at physiological pH. Spectrochim Acta A Mol Biomol Spectrosc. 2011 Nov; 82 (1): 213–6. doi: 10.1016/j. saa.2011.07.037.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Yu Y.Y., Hu X.,Cao S.W. Research on the interactions between genistein and its glucosides with DNA. Guang Pu Xue Yu Guang Pu Fen Xi. 2008 Aug; 28 (8): 1905–9.</mixed-citation><mixed-citation xml:lang="en">Li H., Yu Y.Y., Hu X.,Cao S.W. Research on the interactions between genistein and its glucosides with DNA. Guang Pu Xue Yu Guang Pu Fen Xi. 2008 Aug; 28 (8): 1905–9.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lipfert J., Klijnhout S., Dekker N.H. Torsional sensing of small‐ molecule binding using magnetic tweezers. Nucleic Acids Res. 2010 Nov; 38 (20): 7122–32. doi: 10.1093/nar/gkq598.</mixed-citation><mixed-citation xml:lang="en">Lipfert J., Klijnhout S., Dekker N.H. Torsional sensing of small‐ molecule binding using magnetic tweezers. Nucleic Acids Res. 2010 Nov; 38 (20): 7122–32. doi: 10.1093/nar/gkq598.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Leonova K., Safina A., Nesher E., Sandlesh P., Pratt R., Burkhart C., Lipchick B., Gitlin I., Frangou C., Koman I., Wang J., Kirsanov K., Yakubovskaya M.G., Gudkov A.V., Gurova K. TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells. Elife. 2018 Feb 5; 7. pii: e30842. doi: 10.7554/eLife.30842.</mixed-citation><mixed-citation xml:lang="en">Leonova K., Safina A., Nesher E., Sandlesh P., Pratt R., Burkhart C., Lipchick B., Gitlin I., Frangou C., Koman I., Wang J., Kirsanov K., Yakubovskaya M.G., Gudkov A.V., Gurova K. TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells. Elife. 2018 Feb 5; 7. pii: e30842. doi: 10.7554/eLife.30842.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Safina A., Cheney P., Pal M., Brodsky L., Ivanov A., Kirsanov K., Lesovaya E., Naberezhnov D., Nesher E., Koman I., Wang D., Wang J., Yakubovskaya M., Winkler D., Gurova K. FACT is a sensor of DNA tor‐ sional stress in eukaryotic cells. Nucleic Acids Res. 2017 Feb 28; 45 (4): 1925–45. doi: 10.1093/nar/gkw1366.</mixed-citation><mixed-citation xml:lang="en">Safina A., Cheney P., Pal M., Brodsky L., Ivanov A., Kirsanov K., Lesovaya E., Naberezhnov D., Nesher E., Koman I., Wang D., Wang J., Yakubovskaya M., Winkler D., Gurova K. FACT is a sensor of DNA tor‐ sional stress in eukaryotic cells. Nucleic Acids Res. 2017 Feb 28; 45 (4): 1925–45. doi: 10.1093/nar/gkw1366.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kirsanov K.I., Kotova E., Makhov P., Golovine K., Lesovaya E.A., Kolenko V.M., Yakubovskaya M.G., Tulin A.V. Minor grove binding ligands disrupt PARP‐1 activation pathways. Oncotarget. 2014; 5 (2): 428–37. doi: 10.18632/oncotarget.1742.</mixed-citation><mixed-citation xml:lang="en">Kirsanov K.I., Kotova E., Makhov P., Golovine K., Lesovaya E.A., Kolenko V.M., Yakubovskaya M.G., Tulin A.V. Minor grove binding ligands disrupt PARP‐1 activation pathways. Oncotarget. 2014; 5 (2): 428–37. doi: 10.18632/oncotarget.1742.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Izquierdo-Bouldstridge A., Bustillos A., Bonet-Costa C., AribauMiralbes P., Garcia-Gomis D., Dabad M., Esteve-Codina A., PascualReguant L., Peiro S., Esteller M., Murtha M., Millan-Arino L., Jordan A. Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats. Nucleic Acids Res. 2017; 45 (20): 11622–42. doi: 10.1093/nar/gkx746.</mixed-citation><mixed-citation xml:lang="en">Izquierdo-Bouldstridge A., Bustillos A., Bonet-Costa C., AribauMiralbes P., Garcia-Gomis D., Dabad M., Esteve-Codina A., PascualReguant L., Peiro S., Esteller M., Murtha M., Millan-Arino L., Jordan A. Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats. Nucleic Acids Res. 2017; 45 (20): 11622–42. doi: 10.1093/nar/gkx746.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Z., Meng Q., Zhao Y., Han R., Huang S., Li M., Wu X., Cai W., Wang H. Resveratrol Promoted Interferon‐alpha‐Induced Growth Inhibi‐ tion and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1. J Interferon Cytokine Res. 2018 Jun; 38 (6): 261–271. doi: 10.1089/ jir.2017.0130.</mixed-citation><mixed-citation xml:lang="en">Yang Z., Meng Q., Zhao Y., Han R., Huang S., Li M., Wu X., Cai W., Wang H. Resveratrol Promoted Interferon‐alpha‐Induced Growth Inhibi‐ tion and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1. J Interferon Cytokine Res. 2018 Jun; 38 (6): 261–271. doi: 10.1089/ jir.2017.0130.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Igbe I., Shen X.F., Jiao W., Qiang Z., Deng T., Li S., Liu W.L., Liu H.W., Zhang G.L., Wang F. Dietary quercetin potentiates the anti‐ proliferative effect of interferon‐alpha in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase. Oncotarget. 2017 Nov 20; 8 (69): 113734–748. doi: 10.18632/ oncotarget.22556.</mixed-citation><mixed-citation xml:lang="en">Igbe I., Shen X.F., Jiao W., Qiang Z., Deng T., Li S., Liu W.L., Liu H.W., Zhang G.L., Wang F. Dietary quercetin potentiates the anti‐ proliferative effect of interferon‐alpha in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase. Oncotarget. 2017 Nov 20; 8 (69): 113734–748. doi: 10.18632/ oncotarget.22556.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao L.J., He S.F., Liu Y., Zhao P., Bian ZQ., Qi Z.T. Inhibition of STAT Pathway Impairs Anti‐Hepatitis C Virus Effect of Interferon Alpha. Cell Physiol Biochem. 2016; 40 (1–2): 77–90. doi: 10.1159/000452526.</mixed-citation><mixed-citation xml:lang="en">Zhao L.J., He S.F., Liu Y., Zhao P., Bian ZQ., Qi Z.T. Inhibition of STAT Pathway Impairs Anti‐Hepatitis C Virus Effect of Interferon Alpha. Cell Physiol Biochem. 2016; 40 (1–2): 77–90. doi: 10.1159/000452526.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
